高级检索
当前位置: 首页 > 详情页

Predictive value of preoperative lymphocyte-to-monocyte ratio for patients with upper tract urothelial carcinoma.

文献详情

资源类型:
Pubmed体系:
机构: [1]Department of Urology and Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, China
出处:
ISSN:

关键词: Lymphocyte-to-monocyte ratio Upper tract urothelial carcinoma Prognostic value

摘要:
To determine the predictive value of preoperative lymphocyte-to-monocyte ratio (LMR) for pathological and survival outcomes in upper tract urothelial carcinoma (UTUC) after radical nephroureterectomy (RNU). This retrospective study included 704 UTUC patients between 2008 and 2017. We used a cutoff LMR of 3.6 to evaluate its relationship with oncological outcomes after RNU, using the Kaplan-Meier method and logistic regression models. During median follow-up of 39 months, decreased preoperative LMR was an independent predictor of poor pathological outcomes. Kaplan-Meier analysis revealed that patients with low LMR (<3.6) had poor cancer-specific survival (CSS), recurrence-free survival (RFS), and overall survival (OS); this prognostic value was ascertained for patients with high pathological grade and more advanced stage UTUC, but not for patients with low pathological features. Multivariate Cox proportional hazards model revealed that low LMR was an independent predictor of poor CSS, RFS and OS [hazard ratio (HR) = 1.42, P = 0.02; HR = 1.39, P = 0.008; HR = 1.38, P = 0.017, respectively]. Preoperative low LMR was an independent predictor of poor pathological and oncological outcomes of UTUC after RNU. Subgroup analysis confirmed that the prognostic value of LMR was confined to patients with a high pathological grade and more advanced stage tumor. Copyright © 2019 Elsevier B.V. All rights reserved.

基金:
语种:
PubmedID:
中科院(CAS)分区:
出版当年[2019]版:
大类 | 3 区 医学
小类 | 3 区 医学实验技术
最新[2023]版:
大类 | 3 区 医学
小类 | 3 区 医学实验技术
第一作者:
第一作者机构: [1]Department of Urology and Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, China
共同第一作者:
通讯作者:
通讯机构: [1]Department of Urology and Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, China [*1]Department of Urology and Institute of Urology, West China Hospital, Sichuan University, Number 37, Guoxue Alley, Chengdu, Sichuan 610041, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:43377 今日访问量:0 总访问量:3120 更新日期:2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号